Calma, Shekira F.
HRN: 27-08-72 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/07/2025
CEFTRIAXONE 1G (VIAL)
05/07/2025
05/10/2025
IVT
900mg
OD
Kawasaki Disease
Waiting Final Action
Indication: Empiric Type of Infection: CardiovascularDisseminated Systemic Infection Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes